Skip to Content
Authors Thomas S, Hao L, Ricke WA, Li L
Author Profile(s)
Journal Proteomics Clin Appl Volume: 10 Issue: 4 Pages: 358-70
Publish Date 2016 Apr
PubMed ID 26703953
PMC ID 4888976

Urinary proteomics has become one of the most attractive topics in disease biomarker discovery. MS-based proteomic analysis has advanced continuously and emerged as a prominent tool in the field of clinical bioanalysis. However, only few protein biomarkers have made their way to validation and clinical practice. Biomarker discovery is challenged by many clinical and analytical factors including, but not limited to, the complexity of urine and the wide dynamic range of endogenous proteins in the sample. This article highlights promising technologies and strategies in the MS-based biomarker discovery process, including study design, sample preparation, protein quantification, instrumental platforms, and bioinformatics. Different proteomics approaches are discussed, and progresses in maximizing urinary proteome coverage and standardization are emphasized in this review. MS-based urinary proteomics has great potential in the development of noninvasive diagnostic assays in the future, which will require collaborative efforts between analytical scientists, systems biologists, and clinicians.

Full Text Full text available on PubMed Central Copyright © 2018 The Board of Regents of the University of Wisconsin System